Vanda Pharmaceuticals (VNDA) Inventory (2012 - 2026)
Vanda Pharmaceuticals recorded quarterly Inventory of $10.5 million in Q1 2026, down 4.64% quarter-over-quarter from $11.0 million in Q4 2025, and up 2.2% year-over-year from $10.3 million in Q1 2025.
Vanda Pharmaceuticals' Inventory history runs 15 years deep, the most recent figure standing at $10.5 million for Q1 2026.
- In Q1 2026, Inventory rose 2.2% year-over-year to $10.5 million; the TTM figure through Mar 2026 stood at $10.5 million (up 2.2% YoY), while the FY2025 annual figure was $11.0 million, up 15.84% from the prior year.
- Inventory came in at $10.5 million for Q1 2026 at Vanda Pharmaceuticals, down from $11.0 million in the prior quarter.
- In the past five years, Inventory ranged from a high of $11.5 million in Q4 2022 to a low of $1.1 million in Q1 2023.
- A 5-year average of $7.2 million and a median of $10.0 million in 2025 frame the typical range for Inventory.
- Across the five-year window, Inventory soared 1020.98% in 2022 and tumbled 88.19% in 2023, its largest moves.
- Vanda Pharmaceuticals' Inventory stood at $11.5 million in 2022, then sank by 88.19% to $1.4 million in 2023, then jumped by 601.03% to $9.5 million in 2024, then gained by 15.84% to $11.0 million in 2025, then dropped by 4.64% to $10.5 million in 2026.
- According to Business Quant data, Inventory over the past three periods registered $10.5 million, $11.0 million, and $10.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 32.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.77 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.10 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 84.03 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | 10.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.51 Mn |
| Dec 31, 2025 | 11.02 Mn |
| Sep 30, 2025 | 10.04 Mn |
| Jun 30, 2025 | 10.36 Mn |
| Mar 31, 2025 | 10.28 Mn |
| Dec 31, 2024 | 9.51 Mn |
| Sep 30, 2024 | 1.61 Mn |
| Jun 30, 2024 | 1.47 Mn |
| Mar 31, 2024 | 9.92 Mn |
| Dec 31, 2023 | 1.36 Mn |
| Sep 30, 2023 | 10.24 Mn |
| Jun 30, 2023 | 10.18 Mn |
| Mar 31, 2023 | 1.11 Mn |
| Dec 31, 2022 | 11.49 Mn |
| Sep 30, 2022 | 11.06 Mn |
| Jun 30, 2022 | 1.50 Mn |
| Mar 31, 2022 | 1.29 Mn |
| Dec 31, 2021 | 1.03 Mn |
| Sep 30, 2021 | 8.18 Mn |
| Jun 30, 2021 | 7.64 Mn |
| Mar 31, 2021 | 1.36 Mn |
| Dec 31, 2020 | 1.28 Mn |
| Sep 30, 2020 | 6.70 Mn |
| Jun 30, 2020 | 3.93 Mn |
| Mar 31, 2020 | 1.32 Mn |
| Dec 31, 2019 | 1.14 Mn |
| Sep 30, 2019 | 1.02 Mn |
| Jun 30, 2019 | 1.06 Mn |
| Mar 31, 2019 | 1.11 Mn |
| Dec 31, 2018 | 994,000.00 |
| Sep 30, 2018 | 887,000.00 |
| Jun 30, 2018 | 1.19 Mn |
| Mar 31, 2018 | 1.01 Mn |
| Dec 31, 2017 | 840,000.00 |
| Sep 30, 2017 | 921,000.00 |
| Jun 30, 2017 | 742,000.00 |
| Mar 31, 2017 | 816,000.00 |
| Dec 31, 2016 | 779,000.00 |
| Sep 30, 2016 | 865,000.00 |
| Jun 30, 2016 | 927,000.00 |
| Mar 31, 2016 | 938,000.00 |
| Dec 31, 2015 | 1.29 Mn |
| Sep 30, 2015 | 3.80 Mn |
| Jun 30, 2015 | 4.96 Mn |
| Mar 31, 2015 | 5.22 Mn |
| Dec 31, 2014 | 5.17 Mn |
| Sep 30, 2014 | 608,000.00 |
| Jun 30, 2014 | 608,000.00 |
| Mar 31, 2014 | 192,000.00 |
| Jun 30, 2013 | 28,000.00 |
| Mar 31, 2013 | 21,000.00 |
| Dec 31, 2012 | 57,000.00 |
| Sep 30, 2012 | 161,000.00 |
| Jun 30, 2012 | 165,000.00 |